In contrast, by inclusion of intronic/non-coding regions to cover the TERT promoter with an average coverage of 550-fold, we found pTERT mutations in 85% (n = 46) of the Heidelberg GBM cohort. The gene discussed is TERT; the disease is glioblastoma.